Immunodepression, Infections, and Functional Outcome in Ischemic Stroke

Area of Science:

• Neurology
• Immunology
• Infectious Diseases

Background:

• Stroke is a leading cause of death and disability globally.
• Post-stroke neuroinflammation triggers systemic immunodepression, impairing immune defenses and increasing infection susceptibility.
• Common infections post-stroke include pneumonia and urinary tract infections, often linked to factors like severity and impaired consciousness.

Purpose of the Study:

• To review the epidemiology, risk factors, causes, diagnosis, clinical presentation, and potential treatments for post-stroke immunosuppression and associated infections.
• To highlight the impact of infections on stroke outcomes and explore potential therapeutic targets.

Main Methods:

• This is a review article, synthesizing existing clinical and experimental data.
• The review characterizes post-stroke immunosuppression and its link to infections based on published literature.

Main Results:

• Post-stroke immunosuppression, characterized by lymphopenia and immune cell dysfunction, elevates infection risk.
• Pneumonia is a common complication, significantly increasing mortality and negatively impacting functional outcomes.
• While preventive antibiotics have not improved outcomes, immunomodulatory strategies targeting neuroinflammation are being explored.

Conclusions:

• Effective prevention of post-stroke infections, particularly pneumonia, requires a better understanding of the underlying pathobiology.
• Future strategies may involve optimized antibiotic therapy or immunomodulation to improve long-term stroke patient outcomes.
• Further research is needed to translate experimental findings into clinical practice for stroke-associated immunosuppression.